Clinical Trials Logo

Filter by:
NCT ID: NCT00897871 Recruiting - Clinical trials for Unspecified Childhood Solid Tumor, Protocol Specific

Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer

Start date: February 2007
Phase: N/A
Study type: Observational

RATIONALE: Studying samples of blood in the laboratory from young patients with cancer may help doctors learn how carboplatin, cyclophosphamide, and etoposide affect the body and how patients will respond to treatment. PURPOSE: This laboratory study is evaluating the side effects and how well anticancer drugs work in very young patients with cancer.

NCT ID: NCT00883402 Recruiting - Carotid Stenosis Clinical Trials

Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients

ACST-2
Start date: January 2008
Phase: N/A
Study type: Interventional

The trial randomise patients with asymptomatic carotid artery narrowing in whom prompt physical intervention is thought to be needed, but there there is still substantial uncertainty shared by patient and doctor about whether surgery or stenting is the more appropriate choice. The study is looking at immediate risks (within one month)and at long term benefits

NCT ID: NCT00825929 Recruiting - HIV Infections Clinical Trials

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

PANNA
Start date: February 2009
Phase:
Study type: Observational

Due to the potential for pregnancy-induced changes in the pharmacokinetics of medication, one cannot assume that the currently licensed doses of the medication to be tested under this protocol lead to adequate exposure in an HIV-infected pregnant woman. For the agents under study no or limited pharmacokinetic data during pregnancy are available. As the changes in pharmacokinetics during pregnancy are most prominent in the third trimester a pharmacokinetic curve will be recorded in the third trimester after attaining steady state.

NCT ID: NCT00790140 Recruiting - Esophageal Cancer Clinical Trials

Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery

Start date: July 2005
Phase: Phase 4
Study type: Interventional

This study aims to examine whether providing tube feeding with a formula enriched with omega-3 fats is better than traditional standard tube feeding in terms of preserving nutritional status, improving immune function and reducing medical complications following major upper Gut cancer surgery.

NCT ID: NCT00752817 Recruiting - Colorectal Disease Clinical Trials

Creating a Proficiency-Based Virtual Reality Simulation Training Programme for Laparoscopic Assisted Colectomy

LAC
Start date: September 2008
Phase: N/A
Study type: Interventional

Laparoscopic Colectomy is an advanced minimally invasive procedure that requires advanced laparoscopic skills. Minimally invasive surgery offers many advantages to the patients but exposes the surgeon to new challenges, many of which are human factor in nature. This in turn prolongs the learning curve and has delayed the widespread adoption of minimally invasive surgical techniques in the management of patients with colorectal disease. Virtual reality simulation offers an effective way of training whereby surgical trainees can train repeatedly and achieve proficiency in a shorter time and a safe environment.

NCT ID: NCT00666744 Recruiting - Balance Clinical Trials

A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke

FAME
Start date: April 2008
Phase: Phase 3
Study type: Interventional

The aim of the study is to evaluate the functional recovery in two groups of primary stroke patients presenting with moderate/severe disability over a six month period through the implementation of a randomised controlled trial. The first group or the experimental group will receive routine therapy and additional lower limb exercise therapy in the form of family assisted exercises. The second group or the control group will receive routine therapy with no additional formal input from their family members. A secondary aim of the project is to evaluate the impact of the FAME programme on the person with stroke and the individual (s) assisting in the delivery of exercises.

NCT ID: NCT00553553 Recruiting - Pain Clinical Trials

Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery

RITM-IVM
Start date: September 2007
Phase: N/A
Study type: Interventional

The patient population requiring hepatic resection can demonstrate an unpredictable risk of exhibiting peri-operative coagulopathy resulting either from the pre-operative hepatic pathophysiology or volume of parenchymal resection. Choice of analgesia can be severely limited. Currently, the most commonly described use of combined remifentanil infusion and intrathecal morphine has been in fast-track cardiac surgery. To date, there are no published data describing its use in the context of major hepatobiliary where the investigators predict it may provide adequate analgesia with a lower rate of adverse effects over the first 24 hours after surgery.

NCT ID: NCT00519961 Recruiting - Clinical trials for Peripheral Vascular Disease

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

Start date: February 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.

NCT ID: NCT00514397 Recruiting - Clinical trials for Brain and Central Nervous System Tumors

Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma

Start date: January 2008
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving temozolomide together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving temozolomide together with radiation therapy works in treating young patients with pontine glioma.

NCT ID: NCT00514345 Recruiting - Sarcoma Clinical Trials

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Start date: July 2007
Phase: N/A
Study type: Observational

RATIONALE: Studying the genes expressed in samples of blood from young patients with cancer treated with ifosfamide may help doctors identify risk factors for kidney damage. PURPOSE: This clinical trial is looking at the CYP3A5 gene to see if having the gene may be a risk factor for kidney damage in young patients with cancer treated with ifosfamide.